Journal of cosmetic dermatology · 2025
Intense Pulsed Light Improves Facial Telangiectasia and Acne-Induced Post-Inflammatory Erythema in Systemic Lupus Erythematosus Patient: A Case Report.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Zhen, Lu Jiejie, Wu Miaoting
Аннотация
BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease. Standard treatment typically involves corticosteroids, antimalarials, and immunosuppressants; however, long-term corticosteroid use can lead to adverse cutaneous effects, including facial telangiectasia and acne vulgaris. While medical management often addresses active acne, residual telangiectasia and post-inflammatory erythema (PIE) frequently persist as challenging cosmetic concerns.
AIM: To study the efficacy of intense pulsed light (IPL) in treating facial telangiectasia and PIE in patients with SLE; to record the possible adverse reactions of this treatment.
METHODS: We present a case of a 21-year-old female SLE patient with facial telangiectasia and PIE. The treatment protocol incorporated five sessions of IPL therapy using dual-band vascular filters (530-650 nm and 900-1200 nm) along with a 590 nm filter.
RESULTS: After five sessions of IPL treatment, the facial telangiectasia and PIE of the patient were improved. During the 6-month follow-up period, no adverse reactions and worsening of SLE were observed.
CONCLUSIONS: Low-energy IPL may be a safe and effective therapeutic option for managing steroid-induced telangiectasia and acne-related PIE in SLE patients.
AIM: To study the efficacy of intense pulsed light (IPL) in treating facial telangiectasia and PIE in patients with SLE; to record the possible adverse reactions of this treatment.
METHODS: We present a case of a 21-year-old female SLE patient with facial telangiectasia and PIE. The treatment protocol incorporated five sessions of IPL therapy using dual-band vascular filters (530-650 nm and 900-1200 nm) along with a 590 nm filter.
RESULTS: After five sessions of IPL treatment, the facial telangiectasia and PIE of the patient were improved. During the 6-month follow-up period, no adverse reactions and worsening of SLE were observed.
CONCLUSIONS: Low-energy IPL may be a safe and effective therapeutic option for managing steroid-induced telangiectasia and acne-related PIE in SLE patients.